M&A TRANSACTION · 2023
NextGen Healthcare acquired by Thoma Bravo
$1.80B· Healthtech
Acquirer
Thoma Bravo
Private Equity buyer
Disclosed financials at time of acquisition
Revenue
$653.2M
EBITDA
$111.7M
Deal Value
$1.80B
What's your healthtech worth today?
12-input M&A-grade workup with sellability score, named comparable deals, and AI-written commentary. 2 minutes.
- ✓Sellability score with 5-driver breakdown and lift estimates
- ✓Named comparable M&A transactions in your sub-vertical
- ✓AI-written analysis grounded in your specific inputs
Context
This $1.80B acquisition of NextGen Healthcare by Thoma Bravo sits in the healthtech sub-vertical. Run a valuation for your own healthtech business via our Healthtech valuation hub. Thoma Bravo is acquiring as a private equity buyer; see how PE acquirers typically price healthtech businesses on our Healthtech PE buyer-pool page.
Source
Data sourced from SEC Fairness Opinion - primary source. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology
Value your own healthtech
12-input M&A-grade workup with sellability score, named comparable deals, and AI-written commentary. 2 minutes.
- ✓Sellability score with 5-driver breakdown and lift estimates
- ✓Named comparable M&A transactions in your sub-vertical
- ✓AI-written analysis grounded in your specific inputs
Compare your business to the NextGen Healthcare acquisition.
More on healthtech valuations
- Value a healthtech· run the calculator
- Healthtech median multiples· real-deal benchmarks
- Who buys healthtech businesses?· active buyers
- Who acquired Accolade, Inc.?· buyer profile